跳至主要内容
临床试验/NCT02796989
NCT02796989已完成1 期

The Impact of Modified Wheat Bran on Carbohydrate Fermentation in the Colon in Healthy and Obese Subjects

KU Leuven2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
KU Leuven
入组人数
50
试验地点
2
主要终点
The incremental plasma short-chain fatty acid concentrations will be measured using GC-FID after an intervention with wheat bran/placebo

研究概览

简要总结

During this project the effect of modified wheat bran on colon health and systemic health will be evaluated in a long-term intervention study in healthy and obese subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 65 years old
  • BMI between 18 and 25 kg/m² OR higher than 30 kg/m²
  • Regular diet
  • Not dieting

排除标准

  • Use of antibiotics in the month preceding the study
  • Diabetes Type 1 or 2
  • Abdominal surgery (except from appendectomy)
  • Use of medication that affects the gastrointestinal tract during the last 2 weeks prior to the study including spasmolytics, anti-diarrhoea medication, anti-constipation medication
  • Use of pre- or probiotic supplements in the month preceding the study
  • Chronic gastrointestinal diseases, such as inflammatory bowel disease (Crohn's disease, ulcerative colitis), irritable bowel disease...
  • Pregnancy or lactation
  • Blood donation in the last 3 months
  • Abnormal Hb-level (Standard range between 14 and 18 g/dL for men and between 12 and 16 g/dL for women)
  • Participation in clinical studies involving radiation exposure in the past year

结局指标

主要结局

The incremental plasma short-chain fatty acid concentrations will be measured using GC-FID after an intervention with wheat bran/placebo

时间窗: 1 month

次要结局

  • Gut permeability using 51-Cr-EDTA(1 month)
  • Changes in gut microbiota before and after the intervention using 16S rRNA sequencing(1 month)
  • Changes in glucose levels (mg/dL)(1 month)
  • Changes in cholesterol levels (mg/dL)(1 month)
  • Changes in free fatty acids levels (mmol/L)(1 month)
  • Changes in triglyceride levels (mg/dL)(1 month)
  • Total gastrointestinal transit time(1 month)
  • Changes in insulin levels (pmol/L)(1 month)
  • Changes in metabolite patterns in the feces before and after the intervention using gas chromatography coupled to mass spectrometry(1 month)

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristin Verbeke

Professor Kristin Verbeke

KU Leuven

研究点 (2)

Loading locations...

相似试验